Cargando…

Quit outcomes among clients ineligible for cessation medication through the state quitline: a retrospective, observational study

BACKGROUND: Distribution of tobacco cessation medications through state quitlines increases service utilization and quit outcomes. However, some state quitlines have moved to models in which callers are instructed to obtain quit medications through their health insurance pharmaceutical benefit. We a...

Descripción completa

Detalles Bibliográficos
Autores principales: Lent, Adrienne B., O’Connor, Patrick A., Reikowsky, Ryan C., Nair, Uma S., Bell, Melanie L.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6086054/
https://www.ncbi.nlm.nih.gov/pubmed/30097065
http://dx.doi.org/10.1186/s12889-018-5923-6
_version_ 1783346449521573888
author Lent, Adrienne B.
O’Connor, Patrick A.
Reikowsky, Ryan C.
Nair, Uma S.
Bell, Melanie L.
author_facet Lent, Adrienne B.
O’Connor, Patrick A.
Reikowsky, Ryan C.
Nair, Uma S.
Bell, Melanie L.
author_sort Lent, Adrienne B.
collection PubMed
description BACKGROUND: Distribution of tobacco cessation medications through state quitlines increases service utilization and quit outcomes. However, some state quitlines have moved to models in which callers are instructed to obtain quit medications through their health insurance pharmaceutical benefit. We aimed to investigate the impact of this policy on medication access and quit outcomes in the state quitline setting for clients who must obtain covered medications through the state Medicaid program. We hypothesized that clients with Medicaid who were referred by their healthcare provider would be more likely to report using quit medication and have higher quit rates compared to clients with Medicaid who engaged the quitline on their own. METHODS: An observational, retrospective study was conducted using state quitline clients with Medicaid health insurance who were ineligible for quitline provided cessation medications. Clients were stratified by referral type: self-referred, passively referred, and proactively referred. Unadjusted and adjusted logistic regression was used to estimate the effect of referral type on both quit status and cessation medication use. RESULTS: Proactively referred clients were less likely to use quit medication (53.6%) compared to self (56.9%) and passively referred clients (61.1%). Proactively referred clients had lower quit rates (31.4%), as compared to passively referred (36.0%) and self-referred (35.1%). In adjusted models, proactively referred clients were significantly less likely to be quit than passively referred clients (OR = 0.75, 95% CI: 0.56, 0.99). There were no statistically significant differences in medication use or number of coaching sessions among proactive, passive, and self-referred clients in adjusted models. CONCLUSIONS: In adjusted models, medication use did not significantly differ by mode of entry in this population of Medicaid beneficiaries. Psychosocial factors such as intention to quit in the next 30 days, social support for quitting, education level, race, and ethnicity impacted quit status and differed by mode of entry. Quitlines should use tailored strategies to increase engagement and reduce barriers among proactively referred clients. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1186/s12889-018-5923-6) contains supplementary material, which is available to authorized users.
format Online
Article
Text
id pubmed-6086054
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-60860542018-08-16 Quit outcomes among clients ineligible for cessation medication through the state quitline: a retrospective, observational study Lent, Adrienne B. O’Connor, Patrick A. Reikowsky, Ryan C. Nair, Uma S. Bell, Melanie L. BMC Public Health Research Article BACKGROUND: Distribution of tobacco cessation medications through state quitlines increases service utilization and quit outcomes. However, some state quitlines have moved to models in which callers are instructed to obtain quit medications through their health insurance pharmaceutical benefit. We aimed to investigate the impact of this policy on medication access and quit outcomes in the state quitline setting for clients who must obtain covered medications through the state Medicaid program. We hypothesized that clients with Medicaid who were referred by their healthcare provider would be more likely to report using quit medication and have higher quit rates compared to clients with Medicaid who engaged the quitline on their own. METHODS: An observational, retrospective study was conducted using state quitline clients with Medicaid health insurance who were ineligible for quitline provided cessation medications. Clients were stratified by referral type: self-referred, passively referred, and proactively referred. Unadjusted and adjusted logistic regression was used to estimate the effect of referral type on both quit status and cessation medication use. RESULTS: Proactively referred clients were less likely to use quit medication (53.6%) compared to self (56.9%) and passively referred clients (61.1%). Proactively referred clients had lower quit rates (31.4%), as compared to passively referred (36.0%) and self-referred (35.1%). In adjusted models, proactively referred clients were significantly less likely to be quit than passively referred clients (OR = 0.75, 95% CI: 0.56, 0.99). There were no statistically significant differences in medication use or number of coaching sessions among proactive, passive, and self-referred clients in adjusted models. CONCLUSIONS: In adjusted models, medication use did not significantly differ by mode of entry in this population of Medicaid beneficiaries. Psychosocial factors such as intention to quit in the next 30 days, social support for quitting, education level, race, and ethnicity impacted quit status and differed by mode of entry. Quitlines should use tailored strategies to increase engagement and reduce barriers among proactively referred clients. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1186/s12889-018-5923-6) contains supplementary material, which is available to authorized users. BioMed Central 2018-08-10 /pmc/articles/PMC6086054/ /pubmed/30097065 http://dx.doi.org/10.1186/s12889-018-5923-6 Text en © The Author(s). 2018 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research Article
Lent, Adrienne B.
O’Connor, Patrick A.
Reikowsky, Ryan C.
Nair, Uma S.
Bell, Melanie L.
Quit outcomes among clients ineligible for cessation medication through the state quitline: a retrospective, observational study
title Quit outcomes among clients ineligible for cessation medication through the state quitline: a retrospective, observational study
title_full Quit outcomes among clients ineligible for cessation medication through the state quitline: a retrospective, observational study
title_fullStr Quit outcomes among clients ineligible for cessation medication through the state quitline: a retrospective, observational study
title_full_unstemmed Quit outcomes among clients ineligible for cessation medication through the state quitline: a retrospective, observational study
title_short Quit outcomes among clients ineligible for cessation medication through the state quitline: a retrospective, observational study
title_sort quit outcomes among clients ineligible for cessation medication through the state quitline: a retrospective, observational study
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6086054/
https://www.ncbi.nlm.nih.gov/pubmed/30097065
http://dx.doi.org/10.1186/s12889-018-5923-6
work_keys_str_mv AT lentadrienneb quitoutcomesamongclientsineligibleforcessationmedicationthroughthestatequitlinearetrospectiveobservationalstudy
AT oconnorpatricka quitoutcomesamongclientsineligibleforcessationmedicationthroughthestatequitlinearetrospectiveobservationalstudy
AT reikowskyryanc quitoutcomesamongclientsineligibleforcessationmedicationthroughthestatequitlinearetrospectiveobservationalstudy
AT nairumas quitoutcomesamongclientsineligibleforcessationmedicationthroughthestatequitlinearetrospectiveobservationalstudy
AT bellmelaniel quitoutcomesamongclientsineligibleforcessationmedicationthroughthestatequitlinearetrospectiveobservationalstudy